Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

about

Dental Management of a Young Child Affected by Galactosialidosis and a Gigantic Abdominal Growth.

P2860

Q55028066-7151CFF7-EEF0-4A6E-A38C-3F5F150DC91C

P2860

Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

Item

http://www.wikidata.org/entity/Q38672166

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Galactosialidosis: historic as ...... nd emerging treatment options.

@en

type

Item

label

Galactosialidosis: historic as ...... nd emerging treatment options.

@en

prefLabel

Galactosialidosis: historic as ...... nd emerging treatment options.

@en

P1476

Galactosialidosis: historic as ...... nd emerging treatment options.

@en

P2093

Alessandra d'Azzo

http://www.w3.org/2001/XMLSchema#string

Ida Annunziata

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases

Galactosialidosis: simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities

Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor

Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.

Serine carboxypeptidase SCPEP1 and Cathepsin A play complementary roles in regulation of vasoconstriction via inactivation of endothelin-1

Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism

Direct affinity purification and supramolecular organization of human lysosomal cathepsin A

Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis

A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein"

Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1

P304

131-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21678707.2016.1266933

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28603679

http://www.w3.org/2001/XMLSchema#string

P932

5461780

http://www.w3.org/2001/XMLSchema#string

Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

about

P2860

P2860

Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932